HEADER PLANT PROTEIN 21-APR-05 1ZGD TITLE CHALCONE REDUCTASE COMPLEXED WITH NADP+ AT 1.7 ANGSTROM RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHALCONE REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MEDICAGO SATIVA; SOURCE 3 ORGANISM_TAXID: 3879; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS POLYKETIDE, CHALCONE, DEOXYCHALCONE, ISOFLAVONOID, BIOSYNTHESIS, KEYWDS 2 PLANT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR E.K.BOMATI,M.B.AUSTIN,M.E.BOWMAN,R.A.DIXON,J.P.NOEL REVDAT 4 23-AUG-23 1ZGD 1 REMARK REVDAT 3 24-FEB-09 1ZGD 1 VERSN REVDAT 2 30-AUG-05 1ZGD 1 JRNL REVDAT 1 28-JUN-05 1ZGD 0 JRNL AUTH E.K.BOMATI,M.B.AUSTIN,M.E.BOWMAN,R.A.DIXON,J.P.NOEL JRNL TITL STRUCTURAL ELUCIDATION OF CHALCONE REDUCTASE AND JRNL TITL 2 IMPLICATIONS FOR DEOXYCHALCONE BIOSYNTHESIS JRNL REF J.BIOL.CHEM. V. 280 30496 2005 JRNL REFN ISSN 0021-9258 JRNL PMID 15970585 JRNL DOI 10.1074/JBC.M502239200 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.23 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 412358.020 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.5 REMARK 3 NUMBER OF REFLECTIONS : 68162 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 6900 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.81 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 8738 REMARK 3 BIN R VALUE (WORKING SET) : 0.2710 REMARK 3 BIN FREE R VALUE : 0.2940 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 999 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.009 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4864 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 96 REMARK 3 SOLVENT ATOMS : 417 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.38000 REMARK 3 B22 (A**2) : 5.67000 REMARK 3 B33 (A**2) : -1.29000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.16 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.18 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.820 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.090 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.670 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.950 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.860 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 40.22 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NADP.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : ION.TOP REMARK 3 TOPOLOGY FILE 3 : NADP.TOP REMARK 3 TOPOLOGY FILE 4 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1ZGD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-APR-05. REMARK 100 THE DEPOSITION ID IS D_1000032688. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-JUN-02 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1808 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMETER REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 68162 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 30.230 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 80.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: HUMAN TYPE III 3A-HYDROXYSTEROID DEHYDROGENASE REMARK 200 (PDB ID: 1IHI) REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, MAGNESIUM CHLORIDE, TAPS, REMARK 280 GLYCEROL, DTT, PH 8.5, TEMPERATURE 298K, VAPOR DIFFUSION, REMARK 280 HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 37.22900 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.90700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.90950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.90700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 37.22900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.90950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 SER A 3 REMARK 465 VAL A 4 REMARK 465 MET B 1 REMARK 465 GLY B 2 REMARK 465 SER B 3 REMARK 465 VAL B 4 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 27 26.40 -147.03 REMARK 500 TRP A 195 80.90 -153.25 REMARK 500 SER B 27 25.45 -146.20 REMARK 500 TRP B 195 78.19 -159.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 755 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP B 1755 DBREF 1ZGD A 1 312 UNP Q40309 Q40309_MEDSA 1 312 DBREF 1ZGD B 1 312 UNP Q40309 Q40309_MEDSA 1 312 SEQRES 1 A 312 MET GLY SER VAL GLU ILE PRO THR LYS VAL LEU THR ASN SEQRES 2 A 312 THR SER SER GLN LEU LYS MET PRO VAL VAL GLY MET GLY SEQRES 3 A 312 SER ALA PRO ASP PHE THR CYS LYS LYS ASP THR LYS ASP SEQRES 4 A 312 ALA ILE ILE GLU ALA ILE LYS GLN GLY TYR ARG HIS PHE SEQRES 5 A 312 ASP THR ALA ALA ALA TYR GLY SER GLU GLN ALA LEU GLY SEQRES 6 A 312 GLU ALA LEU LYS GLU ALA ILE GLU LEU GLY LEU VAL THR SEQRES 7 A 312 ARG ASP ASP LEU PHE VAL THR SER LYS LEU TRP VAL THR SEQRES 8 A 312 GLU ASN HIS PRO HIS LEU VAL ILE PRO ALA LEU GLN LYS SEQRES 9 A 312 SER LEU LYS THR LEU GLN LEU ASP TYR LEU ASP LEU TYR SEQRES 10 A 312 LEU ILE HIS TRP PRO LEU SER SER GLN PRO GLY LYS PHE SEQRES 11 A 312 SER PHE PRO ILE ASP VAL ALA ASP LEU LEU PRO PHE ASP SEQRES 12 A 312 VAL LYS GLY VAL TRP GLU SER MET GLU GLU SER LEU LYS SEQRES 13 A 312 LEU GLY LEU THR LYS ALA ILE GLY VAL SER ASN PHE SER SEQRES 14 A 312 VAL LYS LYS LEU GLU ASN LEU LEU SER VAL ALA THR VAL SEQRES 15 A 312 LEU PRO ALA VAL ASN GLN VAL GLU MET ASN LEU ALA TRP SEQRES 16 A 312 GLN GLN LYS LYS LEU ARG GLU PHE CYS ASN ALA HIS GLY SEQRES 17 A 312 ILE VAL LEU THR ALA PHE SER PRO VAL ARG LYS GLY ALA SEQRES 18 A 312 SER ARG GLY PRO ASN GLU VAL MET GLU ASN ASP MET LEU SEQRES 19 A 312 LYS GLU ILE ALA ASP ALA HIS GLY LYS SER VAL ALA GLN SEQRES 20 A 312 ILE SER LEU ARG TRP LEU TYR GLU GLN GLY VAL THR PHE SEQRES 21 A 312 VAL PRO LYS SER TYR ASP LYS GLU ARG MET ASN GLN ASN SEQRES 22 A 312 LEU ARG ILE PHE ASP TRP SER LEU THR LYS GLU ASP HIS SEQRES 23 A 312 GLU LYS ILE ALA GLN ILE LYS GLN ASN ARG LEU ILE PRO SEQRES 24 A 312 GLY PRO THR LYS PRO GLY LEU ASN ASP LEU TYR ASP ASP SEQRES 1 B 312 MET GLY SER VAL GLU ILE PRO THR LYS VAL LEU THR ASN SEQRES 2 B 312 THR SER SER GLN LEU LYS MET PRO VAL VAL GLY MET GLY SEQRES 3 B 312 SER ALA PRO ASP PHE THR CYS LYS LYS ASP THR LYS ASP SEQRES 4 B 312 ALA ILE ILE GLU ALA ILE LYS GLN GLY TYR ARG HIS PHE SEQRES 5 B 312 ASP THR ALA ALA ALA TYR GLY SER GLU GLN ALA LEU GLY SEQRES 6 B 312 GLU ALA LEU LYS GLU ALA ILE GLU LEU GLY LEU VAL THR SEQRES 7 B 312 ARG ASP ASP LEU PHE VAL THR SER LYS LEU TRP VAL THR SEQRES 8 B 312 GLU ASN HIS PRO HIS LEU VAL ILE PRO ALA LEU GLN LYS SEQRES 9 B 312 SER LEU LYS THR LEU GLN LEU ASP TYR LEU ASP LEU TYR SEQRES 10 B 312 LEU ILE HIS TRP PRO LEU SER SER GLN PRO GLY LYS PHE SEQRES 11 B 312 SER PHE PRO ILE ASP VAL ALA ASP LEU LEU PRO PHE ASP SEQRES 12 B 312 VAL LYS GLY VAL TRP GLU SER MET GLU GLU SER LEU LYS SEQRES 13 B 312 LEU GLY LEU THR LYS ALA ILE GLY VAL SER ASN PHE SER SEQRES 14 B 312 VAL LYS LYS LEU GLU ASN LEU LEU SER VAL ALA THR VAL SEQRES 15 B 312 LEU PRO ALA VAL ASN GLN VAL GLU MET ASN LEU ALA TRP SEQRES 16 B 312 GLN GLN LYS LYS LEU ARG GLU PHE CYS ASN ALA HIS GLY SEQRES 17 B 312 ILE VAL LEU THR ALA PHE SER PRO VAL ARG LYS GLY ALA SEQRES 18 B 312 SER ARG GLY PRO ASN GLU VAL MET GLU ASN ASP MET LEU SEQRES 19 B 312 LYS GLU ILE ALA ASP ALA HIS GLY LYS SER VAL ALA GLN SEQRES 20 B 312 ILE SER LEU ARG TRP LEU TYR GLU GLN GLY VAL THR PHE SEQRES 21 B 312 VAL PRO LYS SER TYR ASP LYS GLU ARG MET ASN GLN ASN SEQRES 22 B 312 LEU ARG ILE PHE ASP TRP SER LEU THR LYS GLU ASP HIS SEQRES 23 B 312 GLU LYS ILE ALA GLN ILE LYS GLN ASN ARG LEU ILE PRO SEQRES 24 B 312 GLY PRO THR LYS PRO GLY LEU ASN ASP LEU TYR ASP ASP HET NAP A 755 48 HET NAP B1755 48 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 3 NAP 2(C21 H28 N7 O17 P3) FORMUL 5 HOH *417(H2 O) HELIX 1 1 ASP A 36 GLY A 48 1 13 HELIX 2 2 ALA A 55 GLY A 59 5 5 HELIX 3 3 SER A 60 LEU A 74 1 15 HELIX 4 4 THR A 78 LEU A 82 5 5 HELIX 5 5 TRP A 89 ASN A 93 5 5 HELIX 6 6 HIS A 94 HIS A 96 5 3 HELIX 7 7 LEU A 97 GLN A 110 1 14 HELIX 8 8 ASP A 143 LEU A 157 1 15 HELIX 9 9 SER A 169 SER A 178 1 10 HELIX 10 10 GLN A 197 HIS A 207 1 11 HELIX 11 11 ASN A 231 GLY A 242 1 12 HELIX 12 12 SER A 244 GLN A 256 1 13 HELIX 13 13 ASP A 266 ASN A 273 1 8 HELIX 14 14 THR A 282 ALA A 290 1 9 HELIX 15 15 ASP B 36 GLY B 48 1 13 HELIX 16 16 ALA B 55 GLY B 59 5 5 HELIX 17 17 SER B 60 LEU B 74 1 15 HELIX 18 18 THR B 78 LEU B 82 5 5 HELIX 19 19 TRP B 89 ASN B 93 5 5 HELIX 20 20 LEU B 97 GLN B 110 1 14 HELIX 21 21 ASP B 143 LEU B 157 1 15 HELIX 22 22 SER B 169 SER B 178 1 10 HELIX 23 23 GLN B 197 HIS B 207 1 11 HELIX 24 24 ASN B 231 GLY B 242 1 12 HELIX 25 25 SER B 244 GLN B 256 1 13 HELIX 26 26 ASP B 266 ASN B 273 1 8 HELIX 27 27 THR B 282 ALA B 290 1 9 SHEET 1 A 2 THR A 8 VAL A 10 0 SHEET 2 A 2 LYS A 19 PRO A 21 -1 O MET A 20 N LYS A 9 SHEET 1 B 7 HIS A 51 ASP A 53 0 SHEET 2 B 7 PHE A 83 LEU A 88 1 O PHE A 83 N PHE A 52 SHEET 3 B 7 LEU A 116 ILE A 119 1 O LEU A 118 N LEU A 88 SHEET 4 B 7 ILE A 163 SER A 166 1 O GLY A 164 N TYR A 117 SHEET 5 B 7 VAL A 186 GLU A 190 1 O VAL A 186 N VAL A 165 SHEET 6 B 7 VAL A 210 PHE A 214 1 O PHE A 214 N VAL A 189 SHEET 7 B 7 THR A 259 PHE A 260 1 O THR A 259 N ALA A 213 SHEET 1 C 2 SER A 124 SER A 125 0 SHEET 2 C 2 LEU A 139 LEU A 140 -1 O LEU A 140 N SER A 124 SHEET 1 D 2 ILE A 134 ASP A 135 0 SHEET 2 D 2 THR A 302 LYS A 303 1 O LYS A 303 N ILE A 134 SHEET 1 E 2 THR B 8 VAL B 10 0 SHEET 2 E 2 LYS B 19 PRO B 21 -1 O MET B 20 N LYS B 9 SHEET 1 F 7 HIS B 51 ASP B 53 0 SHEET 2 F 7 PHE B 83 LEU B 88 1 O PHE B 83 N PHE B 52 SHEET 3 F 7 LEU B 116 ILE B 119 1 O LEU B 118 N LEU B 88 SHEET 4 F 7 ILE B 163 SER B 166 1 O GLY B 164 N TYR B 117 SHEET 5 F 7 VAL B 186 GLU B 190 1 O VAL B 186 N VAL B 165 SHEET 6 F 7 VAL B 210 PHE B 214 1 O PHE B 214 N VAL B 189 SHEET 7 F 7 THR B 259 PHE B 260 1 O THR B 259 N ALA B 213 SHEET 1 G 2 SER B 124 SER B 125 0 SHEET 2 G 2 LEU B 139 LEU B 140 -1 O LEU B 140 N SER B 124 SHEET 1 H 2 ILE B 134 ASP B 135 0 SHEET 2 H 2 THR B 302 LYS B 303 1 O LYS B 303 N ILE B 134 CISPEP 1 PHE A 132 PRO A 133 0 -0.07 CISPEP 2 LYS A 303 PRO A 304 0 -0.07 CISPEP 3 PHE B 132 PRO B 133 0 -0.16 CISPEP 4 LYS B 303 PRO B 304 0 -0.19 SITE 1 AC1 31 GLY A 26 SER A 27 ALA A 28 ASP A 30 SITE 2 AC1 31 ASP A 53 TYR A 58 LYS A 87 HIS A 120 SITE 3 AC1 31 SER A 166 ASN A 167 GLN A 188 PHE A 214 SITE 4 AC1 31 SER A 215 PRO A 216 VAL A 217 ARG A 218 SITE 5 AC1 31 LYS A 219 GLY A 220 ALA A 246 VAL A 261 SITE 6 AC1 31 PRO A 262 LYS A 263 SER A 264 ARG A 269 SITE 7 AC1 31 ASN A 273 HOH A 788 HOH A 797 HOH A 863 SITE 8 AC1 31 HOH A 878 HOH A 889 HOH A 922 SITE 1 AC2 33 GLY B 26 SER B 27 ALA B 28 ASP B 30 SITE 2 AC2 33 ASP B 53 TYR B 58 LYS B 87 HIS B 120 SITE 3 AC2 33 SER B 166 ASN B 167 GLN B 188 PHE B 214 SITE 4 AC2 33 SER B 215 PRO B 216 VAL B 217 ARG B 218 SITE 5 AC2 33 LYS B 219 GLY B 220 ALA B 246 PRO B 262 SITE 6 AC2 33 LYS B 263 SER B 264 TYR B 265 ARG B 269 SITE 7 AC2 33 ASN B 273 HOH B1781 HOH B1832 HOH B1851 SITE 8 AC2 33 HOH B1891 HOH B1893 HOH B1908 HOH B1927 SITE 9 AC2 33 HOH B1937 CRYST1 74.458 85.819 103.814 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013430 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011652 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009633 0.00000